Results 71 to 80 of about 478,778 (207)
Background: Risk Evaluation and Mitigation Strategies (REMS) are safety programs that U.S. Food and Drug Administration can require to ensure a drug's benefits outweigh its risks and can be considered public health interventions.
Gita A. Toyserkani+4 more
doaj +1 more source
Botulinum toxin type A for the management of glabellar rhytids [PDF]
There is an increasing demand for minimally-invasive cosmetic procedures to arrest the aging process. Botulinum toxin type A injections are the most commonly used nonsurgical cosmetic procedures in the United States. There has been research spanning over
McCullough, Jerry L+1 more
core +2 more sources
The ethics and politics of compulsory HPV vaccination [PDF]
On September 12, 2006, 3 months after the Food and Drug Administration licensed a vaccine against human papillomavirus (HPV), Michigan lawmakers became the first in the United States to propose that vaccination be compulsory for girls entering sixth ...
Colgrove, James K.
core +2 more sources
In 2021, the U.S. Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and state partners investigated a multistate outbreak of Salmonella Typhimurium illnesses linked to packaged leafy greens from a controlled ...
Monica McClure+22 more
doaj
The Conflict Between the FDA’s Pre-Launch Activities Importation Request Program and the Hatch-Waxman Act [PDF]
In 2008, the Food and Drug Administration (FDA) implemented the Pre- Launch Activities Importation Request (PLAIR) program. The FDA exercises its enforcement discretion under the guise of the PLAIR program to permit drug manufacturers to import ...
Avery, Matthew, Cheng, Alex
core +1 more source
Forum: Enabling HIV self-testing in South Africa [PDF]
In a South African context, we consider the implications of the United States Food and Drug Administration’s recent approval of the OraQuick HIV self-testing kit.
Gray, A, Richter, ML, Venter, WDF
core +1 more source
The 2020 FDA drug-drug interaction (DDI) guidance includes a consideration for metabolites with structural alerts for potential mechanism-based inhibition (MBI) and describes how this information may be used to determine whether in vitro studies need to ...
Sadegh Faramarzi+6 more
doaj +1 more source
Systems validation: application to statistical programs [PDF]
BACKGROUND: In 2003, the United States Food and Drug Administration (FDA) released a guidance document on the scope of "Part 11" enforcement. In this guidance document, the FDA indicates an expectation of a risk-based approach to determining which ...
D Moher+5 more
core +3 more sources
This study assessed the growth of Listeria monocytogenes in milkshakes made using the process-contaminated ice cream associated with a listeriosis outbreak in comparison to milkshakes made with artificially contaminated ice cream.
Joelle K. Salazar+6 more
doaj +1 more source
Imports From China and Food Safety Issues [PDF]
The U.S. Food and Drug Administration’s (FDA) increased attention to food imports from China is an indicator of safety concerns as imported food becomes more common in the United States. U.S.
Buzby, Jean C., Gale, H. Frederick, Jr.
core +1 more source